Genetics Generation Advancement Corp. Statistics
Genetics Generation Advancement Corp. (4160) Stock Statistics & Valuation Metrics
Total Valuation
Genetics Generation Advancement Corp. has a market cap or net worth of TWD 935.66M. The enterprise value is TWD 874.39M.
- Market Cap
- TWD 935.66M
- Enterprise Value
- TWD 874.39M
Share Statistics
Genetics Generation Advancement Corp. has 28,013,735 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 28,013,735
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Genetics Generation Advancement Corp.’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 1.36%.
- Return on Equity (ROE)
- 0.04
- Return on Assets (ROA)
- 0.03
- Return on Invested Capital (ROIC)
- 1.36%
- Return on Capital Employed (ROCE)
- 0.02
- Revenue Per Employee
- 3.57M
- Profits Per Employee
- 126.96K
- Employee Count
- 169
- Asset Turnover
- 0.75
- Inventory Turnover
- 4.95
Valuation Ratios
The current PE Ratio of Genetics Generation Advancement Corp. is 51.30. Genetics Generation Advancement Corp.’s PEG ratio is -1.17.
- PE Ratio
- 51.30
- PS Ratio
- 1.58
- PB Ratio
- 1.89
- Price to FCF
- -27.07
- Price to Operating Cash Flow
- -6671.82
- PEG Ratio
- -1.17
Income Statement
In the last 12 months, Genetics Generation Advancement Corp. had revenue of 603.11M and earned 21.46M in profits. Earnings per share was 0.80.
- Revenue
- 603.11M
- Gross Profit
- 250.44M
- Operating Income
- 11.82M
- Pretax Income
- 27.42M
- Net Income
- 21.46M
- EBITDA
- 37.22M
- Earnings Per Share (EPS)
- 0.80
Cash Flow
In the last 12 months, operating cash flow was -140.00K and capital expenditures -35.76M, giving a free cash flow of -35.90M billion.
- Operating Cash Flow
- -140.00K
- Free Cash Flow
- -35.90M
- Free Cash Flow per Share
- -1.33
Dividends & Yields
Genetics Generation Advancement Corp. pays an annual dividend of ―, resulting in a dividend yield of 5.27%
- Dividend Per Share
- ―
- Dividend Yield
- 5.27%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -3.69%
- Earnings Yield
- 1.93%
Stock Price Statistics
- Beta
- 0.49
- 52-Week Price Change
- -35.44%
- 50-Day Moving Average
- 38.10
- 200-Day Moving Average
- 40.52
- Relative Strength Index (RSI)
- 21.59
- Average Volume (3m)
- 32.74K
Important Dates
Genetics Generation Advancement Corp. upcoming earnings date is Nov 17, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 13, 2026
- Next Earnings Date
- Nov 17, 2026
- Ex-Dividend Date
- ―
Financial Position
Genetics Generation Advancement Corp. as a current ratio of 3.10, with Debt / Equity ratio of 13.31%
- Current Ratio
- 3.10
- Quick Ratio
- 2.74
- Debt to Market Cap
- 0.06
- Net Debt to EBITDA
- 0.39
- Interest Coverage Ratio
- 18.50
Taxes
In the past 12 months, Genetics Generation Advancement Corp. has paid 5.96M in taxes.
- Income Tax
- 5.96M
- Effective Tax Rate
- 0.22
Enterprise Valuation
Genetics Generation Advancement Corp. EV to EBITDA ratio is 34.28, with an EV/FCF ratio of -28.27.
- EV to Sales
- 1.65
- EV to EBITDA
- 34.28
- EV to Free Cash Flow
- -28.27
- EV to Operating Cash Flow
- -7250.54
Balance Sheet
Genetics Generation Advancement Corp. has TWD 320.81M in cash and marketable securities with TWD 126.53M in debt, giving a net cash position of TWD 194.27M billion.
- Cash & Marketable Securities
- TWD 320.81M
- Total Debt
- TWD 126.53M
- Net Cash
- TWD 194.27M
- Net Cash Per Share
- TWD 6.93
- Tangible Book Value Per Share
- TWD 17.45
Margins
Gross margin is 41.31%, with operating margin of 0.29%, and net profit margin of 2.93%.
- Gross Margin
- 41.31%
- Operating Margin
- 0.29%
- Pretax Margin
- 3.15%
- Net Profit Margin
- 2.93%
- EBITDA Margin
- 4.82%
- EBIT Margin
- 0.97%
Analyst Forecast
The average price target for Genetics Generation Advancement Corp. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 0.10%
- EPS Growth Forecast
- -44.49%
